Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis.

Catanzaro DG, Trollip AP, Seifert M, Georghiou SB, Garfein RS, Rodwell TC, Catanzaro A, Eisenach KD.

Eur Respir J. 2017 Apr 5;49(4). pii: 1602215. doi: 10.1183/13993003.02215-2016. Print 2017 Apr. No abstract available.

2.

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.

Demers AM, Venter A, Friedrich SO, Rojas-Ponce G, Mapamba D, Jugheli L, Sasamalo M, Almeida D, Dorasamy A, Jentsch U, Gibson M, Everitt D, Eisenach KD, Diacon AH.

J Clin Microbiol. 2016 May;54(5):1276-81. doi: 10.1128/JCM.03162-15. Epub 2016 Feb 24.

3.

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.

Domínguez J, Boettger EC, Cirillo D, Cobelens F, Eisenach KD, Gagneux S, Hillemann D, Horsburgh R, Molina-Moya B, Niemann S, Tortoli E, Whitelaw A, Lange C; TBNET; RESIST-TB networks.

Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42. doi: 10.5588/ijtld.15.0221. Review.

PMID:
26688526
4.

What is the most reliable solid culture medium for tuberculosis treatment trials?

Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD.

Tuberculosis (Edinb). 2014 May;94(3):311-6. doi: 10.1016/j.tube.2014.03.002. Epub 2014 Mar 19.

PMID:
24698569
5.

How we determined the most reliable solid medium for studying treatment of tuberculosis.

Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV.

Tuberculosis (Edinb). 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006. Epub 2014 Mar 4.

6.

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

Kirenga BJ, Levin J, Ayakaka I, Worodria W, Reilly N, Mumbowa F, Nabanjja H, Nyakoojo G, Fennelly K, Nakubulwa S, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Mugerwa RD, Smith PG, Ellner JJ, Jones-López EC.

PLoS One. 2014 Mar 7;9(3):e90614. doi: 10.1371/journal.pone.0090614. eCollection 2014.

7.

A metabolic biosignature of early response to anti-tuberculosis treatment.

Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT.

BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53.

8.

Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing.

Clark TG, Mallard K, Coll F, Preston M, Assefa S, Harris D, Ogwang S, Mumbowa F, Kirenga B, O'Sullivan DM, Okwera A, Eisenach KD, Joloba M, Bentley SD, Ellner JJ, Parkhill J, Jones-López EC, McNerney R.

PLoS One. 2013 Dec 11;8(12):e83012. doi: 10.1371/journal.pone.0083012. eCollection 2013.

9.

Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.

Bark CM, Gitta P, Ogwang S, Nsereko M, Thiel BA, Boom WH, Eisenach KD, Joloba ML, Johnson JL.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1448-51. doi: 10.5588/ijtld.13.0063.

PMID:
24125449
10.

Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis.

Fennelly KP, Jones-López EC, Ayakaka I, Kim S, Menyha H, Kirenga B, Muchwa C, Joloba M, Dryden-Peterson S, Reilly N, Okwera A, Elliott AM, Smith PG, Mugerwa RD, Eisenach KD, Ellner JJ.

Am J Respir Crit Care Med. 2012 Sep 1;186(5):450-7. doi: 10.1164/rccm.201203-0444OC. Epub 2012 Jul 12.

11.

Evaluation of Capilia TB assay for rapid identification of Mycobacterium tuberculosis complex in BACTEC MGIT 960 and BACTEC 9120 blood cultures.

Muchwa C, Akol J, Etwom A, Morgan K, Orikiriza P, Mumbowa F, Odong PR, Kateete DP, Eisenach KD, Joloba ML.

BMC Res Notes. 2012 Jan 19;5:44. doi: 10.1186/1756-0500-5-44.

12.

A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.

Mahapatra S, Woolhiser LK, Lenaerts AJ, Johnson JL, Eisenach KD, Joloba ML, Boom WH, Belisle JT.

Antimicrob Agents Chemother. 2012 Jan;56(1):28-35. doi: 10.1128/AAC.05486-11. Epub 2011 Oct 28.

13.

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W; National Institutes of Health; Centers for Disease Control and Prevention.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):972-9. doi: 10.1164/rccm.201105-0827WS.

14.

Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.

Jones-López EC, Ayakaka I, Levin J, Reilly N, Mumbowa F, Dryden-Peterson S, Nyakoojo G, Fennelly K, Temple B, Nakubulwa S, Joloba ML, Okwera A, Eisenach KD, McNerney R, Elliott AM, Ellner JJ, Smith PG, Mugerwa RD.

PLoS Med. 2011 Mar;8(3):e1000427. doi: 10.1371/journal.pmed.1000427. Epub 2011 Mar 15.

15.

Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures.

Bark CM, Okwera A, Joloba ML, Thiel BA, Nakibali JG, Debanne SM, Boom WH, Eisenach KD, Johnson JL.

Tuberculosis (Edinb). 2011 May;91(3):257-9. doi: 10.1016/j.tube.2011.01.004. Epub 2011 Feb 25.

16.

Rhomboid homologs in mycobacteria: insights from phylogeny and genomic analysis.

Kateete DP, Okee M, Katabazi FA, Okeng A, Asiimwe J, Boom HW, Eisenach KD, Joloba ML.

BMC Microbiol. 2010 Oct 29;10:272. doi: 10.1186/1471-2180-10-272.

17.

The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.

Converse PJ, Eisenach KD, Theus SA, Nuermberger EL, Tyagi S, Ly LH, Geiman DE, Guo H, Nolan ST, Akar NC, Klinkenberg LG, Gupta R, Lun S, Karakousis PC, Lamichhane G, McMurray DN, Grosset JH, Bishai WR.

PLoS One. 2010 Apr 21;5(4):e10289. doi: 10.1371/journal.pone.0010289.

18.

Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.

Li L, Mahan CS, Palaci M, Horter L, Loeffelholz L, Johnson JL, Dietze R, Debanne SM, Joloba ML, Okwera A, Boom WH, Eisenach KD.

J Clin Microbiol. 2010 Jan;48(1):46-51. doi: 10.1128/JCM.01526-09. Epub 2009 Nov 18.

19.

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.

Ogwang S, Asiimwe BB, Traore H, Mumbowa F, Okwera A, Eisenach KD, Kayes S, Jones-López EC, McNerney R, Worodria W, Ayakaka I, Mugerwa RD, Smith PG, Ellner J, Joloba ML.

BMC Infect Dis. 2009 Aug 26;9:139. doi: 10.1186/1471-2334-9-139.

20.

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, Okwera A, Mugerwa RD, Alcaneses MR, Quelapio MI, Tupasi TE, Horter L, Debanne SM, Eisenach KD, Boom WH.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):558-63. doi: 10.1164/rccm.200904-0536OC. Epub 2009 Jun 19.

21.

Evaluation of low-colony-number counts of Mycobacterium tuberculosis on solid media as a microbiological marker of cross-contamination.

Ribeiro FK, Lemos EM, Hadad DJ, Leão SC, Viana-Niero C, Dietze R, Johnson JL, Eisenach KD, Palaci M.

J Clin Microbiol. 2009 Jun;47(6):1950-2. doi: 10.1128/JCM.00626-09. Epub 2009 Apr 8.

22.

Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs.

Palanisamy GS, DuTeau N, Eisenach KD, Cave DM, Theus SA, Kreiswirth BN, Basaraba RJ, Orme IM.

Tuberculosis (Edinb). 2009 May;89(3):203-9. doi: 10.1016/j.tube.2009.01.005. Epub 2009 Feb 28.

PMID:
19251482
23.

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda.

Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, Worodria W, Levin J, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Smith PG, Mugerwa RD, Ellner JJ, Jones-López EC.

Clin Infect Dis. 2008 Nov 1;47(9):1126-34. doi: 10.1086/592252.

24.

Use of in-house PCR for identification of Mycobacterium tuberculosis in BACTEC broth cultures of respiratory specimens.

Gouveia AC, Eisenach KD, Vinhas SA, Ribeiro FK, Peres RL, Dietze R, Hadad DJ, Palaci M.

Mem Inst Oswaldo Cruz. 2008 Jun;103(4):386-91.

25.

Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

Palaci M, Dietze R, Hadad DJ, Ribeiro FK, Peres RL, Vinhas SA, Maciel EL, do Valle Dettoni V, Horter L, Boom WH, Johnson JL, Eisenach KD.

J Clin Microbiol. 2007 Dec;45(12):4064-6. Epub 2007 Oct 10.

26.

Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda.

Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K, Kayes S, Jones-Lopez EC, Smith PG, Ellner JJ, Mugerwa RD, Eisenach KD, McNerney R.

Ann Clin Microbiol Antimicrob. 2007 Jan 9;6:1.

27.

Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country.

Muhumuza J, Asiimwe BB, Kayes S, Mugyenyi R, Whalen C, Mugerwa RD, Boom H, Eisenach KD, Joloba ML.

Int J Tuberc Lung Dis. 2006 Nov;10(11):1262-7.

PMID:
17131786
28.

Variable-number tandem repeats that are useful in genotyping isolates of Salmonella enterica subsp. enterica serovars Typhimurium and Newport.

Witonski D, Stefanova R, Ranganathan A, Schutze GE, Eisenach KD, Cave MD.

J Clin Microbiol. 2006 Nov;44(11):3849-54. Epub 2006 Aug 30.

29.

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.

Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9.

30.

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Johnson JL, Hadad DJ, Boom WH, Daley CL, Peloquin CA, Eisenach KD, Jankus DD, Debanne SM, Charlebois ED, Maciel E, Palaci M, Dietze R.

Int J Tuberc Lung Dis. 2006 Jun;10(6):605-12.

PMID:
16776446
31.

Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbón MH, Bobadilla del Valle M, Fyfe J, García-García L, Rastogi N, Sola C, Zozio T, Guerrero MI, León CI, Crabtree J, Angiuoli S, Eisenach KD, Durmaz R, Joloba ML, Rendón A, Sifuentes-Osornio J, Ponce de León A, Cave MD, Fleischmann R, Whittam TS, Alland D.

J Bacteriol. 2006 Jan;188(2):759-72. Erratum in: J Bacteriol. 2006 Apr;188(8):3162-3.

32.

Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance.

Hazbón MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, Davidow A, Brimacombe M, León CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de León A, Cave MD, Alland D.

Antimicrob Agents Chemother. 2005 Sep;49(9):3794-802. Erratum in: Antimicrob Agents Chemother. 2005 Nov;49(11):4818.

33.

Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions.

Cronjé L, Edmondson N, Eisenach KD, Bornman L.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):103-12. Epub 2005 Mar 30.

34.

Epidemiologic import of tuberculosis cases whose isolates have similar but not identical IS6110 restriction fragment length polymorphism patterns.

Cave MD, Yang ZH, Stefanova R, Fomukong N, Ijaz K, Bates J, Eisenach KD.

J Clin Microbiol. 2005 Mar;43(3):1228-33.

35.

Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics.

Theus SA, Cave MD, Eisenach KD.

J Infect Dis. 2005 Feb 1;191(3):453-60. Epub 2004 Dec 30.

PMID:
15633105
37.

Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

Johnson JL, Ssekasanvu E, Okwera A, Mayanja H, Hirsch CS, Nakibali JG, Jankus DD, Eisenach KD, Boom WH, Ellner JJ, Mugerwa RD; Uganda-Case Western Reserve University Research Collaboration.

Am J Respir Crit Care Med. 2003 Jul 15;168(2):185-91. Epub 2003 Apr 17.

PMID:
12702550
38.

Transmission of Mycobacterium tuberculosis in a rural community, Arkansas, 1945-2000.

Dillaha JA, Yang Z, Ijaz K, Eisenach KD, Cave MD, Wilson FJ, Stead WW, Bates JH.

Emerg Infect Dis. 2002 Nov;8(11):1246-8.

39.

Priming reverse transcription with oligo(dT) does not yield representative samples of Mycobacterium tuberculosis cDNA.

Lakey DL, Zhang Y, Talaat AM, Samten B, DesJardin LE, Eisenach KD, Johnston SA, Barnes PF.

Microbiology. 2002 Aug;148(Pt 8):2567-72.

PMID:
12177350
40.

Diversity of Campylobacter isolates from retail poultry carcasses and from humans as demonstrated by pulsed-field gel electrophoresis.

Dickins MA, Franklin S, Stefanova R, Schutze GE, Eisenach KD, Wesley I, Cave MD.

J Food Prot. 2002 Jun;65(6):957-62.

PMID:
12092728
41.

Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Desjardin LE, Hayes LG, Sohaskey CD, Wayne LG, Eisenach KD.

J Bacteriol. 2001 Sep;183(18):5311-6.

42.

Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.

Joloba ML, Johnson JL, Namale A, Morrissey A, Assegghai AE, Rüsch-Gerdes S, Mugerwa RD, Ellner JJ, Eisenach KD.

Int J Tuberc Lung Dis. 2001 Jun;5(6):579-82.

PMID:
11409588
43.

A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico.

Yang ZH, Rendon A, Flores A, Medina R, Ijaz K, Llaca J, Eisenach KD, Bates JH, Villarreal A, Cave MD.

Int J Tuberc Lung Dis. 2001 Apr;5(4):313-20.

PMID:
11334249
44.
45.

An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes.

Wilkinson RJ, DesJardin LE, Islam N, Gibson BM, Kanost RA, Wilkinson KA, Poelman D, Eisenach KD, Toossi Z.

Mol Microbiol. 2001 Feb;39(3):813-21. Erratum in: Mol Microbiol. 2004 Aug;53(3):1001.

46.
47.

Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis.

Beggs ML, Eisenach KD, Cave MD.

J Clin Microbiol. 2000 Aug;38(8):2923-8.

48.

Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.

Joloba ML, Johnson JL, Namale A, Morrissey A, Assegghai AE, Mugerwa RD, Ellner JJ, Eisenach KD.

Int J Tuberc Lung Dis. 2000 Jun;4(6):528-36.

PMID:
10864183
49.

Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.

Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR.

East Afr Med J. 2000 Feb;77(2):111-5.

PMID:
10774085
50.

Species identification of Mycobacterium avium complex isolates by a variety of molecular techniques.

Beggs ML, Stevanova R, Eisenach KD.

J Clin Microbiol. 2000 Feb;38(2):508-12.

Supplemental Content

Loading ...
Support Center